Mechanisms, Equipment, HazardsViscoelastic Haemostatic Point-of-Care Assays in the Management of Postpartum Haemorrhage: A Narrative ReviewDias, J.D.; Butwick, A.J.; Hartmann, J.; Waters, J.H. Author Information Medical Affairs, Haemonetics Corporation, Boston, MA Obstetric Anesthesia Digest 43(1):p 16, March 2023. | DOI: 10.1097/01.aoa.0000912260.60583.59 Buy Metrics Abstract (Anaesthesia. 2022;77:700–711) Viscoelastic hemostatic assays (VHA) provide the benefit of real-time information on pregnant women that laboratory hemostatic analysis does not offer. The speed of VHA contributes to its clinical utility as they help diagnose coagulopathy and guide treatment in real-time for maternal patients. This paper investigates current VHA guidelines in postpartum hemorrhage (PPH; defined as blood loss of ≥500 mL within 24 h of delivery) situations, and it reviews recent literature regarding VHA device use when managing postpartum hemostatic competence profiles of women with PPH. Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
